The new editorial by Jamal Tazi has been published in Drug Discovery Today, focusing on the molecular mechanism of action of obefazimod.
This publication summarizes over ten years of research on the CBC–ARS2 complex and miR-124 expression, with significant implications for RNA biology and innovative therapeutic strategies.
